| 1 |
Chen C, Ke J, Zhou XE, et al. Structural basis for molecular recognition of folic acid by folate receptors[J]. Nature, 2013, 500(7463): 486-489.
|
| 2 |
Scaranti M, Cojocaru E, Banerjee S, et al. Exploiting the folate receptor alpha in oncology[J]. Nat Rev Clin Oncol, 2020, 17(6): 349-359.
|
| 3 |
Parker N, Turk MJ, Westrick E, et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay[J]. Anal Biochem, 2005, 338(2): 284-293.
|
| 4 |
Danila DC, Heller G, Gignac GA, et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer[J]. Clin Cancer Res, 2007, 13(23): 7053-7058.
|
| 5 |
He W, Wang H, Hartmann LC, et al. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry[J]. Proc Natl Acad Sci USA, 2007, 104(28): 11760-11765.
|
| 6 |
Yoon SO, Kim YT, Jung KC, et al. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients[J]. Lung Cancer, 2011, 71(2): 209-216.
|
| 7 |
Hou JM, Krebs MG, Lancashire L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer[J]. J Clin Oncol, 2012, 30(5): 525-532.
|
| 8 |
Chen X, Zhou F, Li X, et al. Folate receptor-positive circulating tumor cell detected by LT-PCR-based method as a diagnostic biomarker for non-small-cell lung cancer[J]. J Thorac Oncol, 2015, 10(8): 1163-1171.
|
| 9 |
Shen J, Zhao J, Jiang T, et al. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy[J]. Oncotarget, 2017, 8(30): 49044-49052.
|
| 10 |
Chen X, Zhou C, Li X, et al. 156P: Correlation of baseline value of folate receptor-positive circulating tumor cells and efficacy of pemetrexed and dynamic monitoring study in NSCLC patients receiving first-line platinum-based chemotherapy[J]. J Thorac Oncol, 2016, 11(4): S125-S126.
|
| 11 |
冯骁, 仓顺东. 中国肺癌筛查标准(T/CPMA 013-2020)解读[J]. 中华实用诊断与治疗杂志, 2021, 35(3): 217-219.
|
| 12 |
Gao S, Li N, Wang S, et al. Lung cancer in People's Republic of China[J]. J Thorac Oncol, 2020, 15(10): 1567-1576.
|
| 13 |
刘洋. 肿瘤标志物检验在肺癌诊断中的临床价值分析[J]. 当代医学, 2021, 27(36): 97-98.
|
| 14 |
何华, 胡诚, 钟田雨, 等. CEA, NSE, CYFRA21-1, ProGRP联合检测在肺癌诊断中的临床价值[J]. 实验与检验医学, 2019, 37(3): 435-437.
|
| 15 |
周景鑫, 王雪霁. NSE、SCC、CYFRA21-1、CA125联合检测诊断肺癌的临床价值[J]. 中国民康医学, 2018, 30(11): 56-58.
|
| 16 |
Schillaci O, Calabria FF. Comments on characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis[J]. J Thorac Dis, 2015, 7(10): 1708-1712.
|
| 17 |
Lou J, Ben S, Yang G, et al. Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR[J]. PLoS One, 2013, 8(12): e80458.
|
| 18 |
Yu Y, Chen Z, Dong J, et al. Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer[J]. Transl Oncol, 2013, 6(6): 697-702.
|
| 19 |
Wan JW, Gao MZ, Hu RJ, et al. A preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer[J]. Ann Transl Med, 2015, 3(22): 352.
|
| 20 |
Zito Marino F, Ronchi A, Accardo M, et al. Detection of folate receptor-positive circulating tumor cells by ligand-targeted polymerase chain reaction in non-small cell lung cancer patients[J]. J Thorac Dis, 2016, 8(7): 1437-1439.
|
| 21 |
Ding C, Zhou X, Xu C, et al. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma[J]. Thorac Cancer, 2018, 9(11): 1413-1420.
|
| 22 |
Lian H, Ding Z, Yuan D, et al. Diagnostic value of folate receptor-positive circulating tumor cell in lung cancer: A Pilot Study[J]. Chin J Lung Cancer, 2016, 19(12): 813-820.
|
| 23 |
郭巧梅, 乔理华, 王琳, 等. 循环肿瘤细胞检测对非小细胞肺癌的诊断价值[J]. 中华检验医学杂志, 2016, 39(8): 589-594.
|
| 24 |
Krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer[J]. J Clin Oncol, 2011, 29(12): 1556-1563.
|
| 25 |
Zhou Q, Geng Q, Wang L, et al. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness[J]. EBioMedicine, 2019, 41: 236-243.
|
| 26 |
Wang L, Wu C, Qiao L, et al. Clinical significance of folate receptor-positive circulating tumor cells detected by Ligand-targeted polymerase chain reaction in lung cancer[J]. J Cancer, 2017, 8(1): 104-110.
|
| 27 |
Wei S, Guo C, He J, et al. Effect of Vein-First vs Artery-First surgical technique on circulating tumor cells and survival in patients with non-small cell lung cancer: A randomized clinical trial and registry-based propensity score matching analysis[J]. JAMA Surg, 2019, 154(7): e190972.
|
| 28 |
Su CX, Li X, Ren S, et al. Circulating tumor cells and evaluation of targeted therapy effect in EGFR mutation/ALK translocation metastatic non-small cell lung cancer[J]. J Clin Oncol, 2015, 33: e19084-e19084.
|
| 29 |
Jiang T, Zhao J, Zhao C, et al. Dynamic monitoring and predictive value of circulating tumor cells in EGFR-mutated advanced non-small-cell lung cancer patients treated with first-line EGFR tyrosine kinase inhibitors[J]. Clin Lung Cancer, 2019, 20(2): 124-133.
|
| 30 |
Xue Y, Cong W, Xie S, et al. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules[J]. J Cancer Res Ther, 2018, 14(7): 1620-1626.
|
| 31 |
Li N, Zhong D, Chen H, et al. The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population[J]. Cancer Manag Res, 2019, 11: 4097-4107.
|